View more on these topics

Skandia appoints Mike Smith as head of offshore investment sales

Skandia appoints Mike Smith as head of investment sales – offshore, joining from Gartmore, where he was head of UK retail distribution.

Smith will be responsible for the sales of Skandia Investment Management Limited’s investment products to intermediaries in overseas markets and will work closely with Royal Skandia.

SIML chief executive Jamie MacLeod says: “Mike’s appointment clearly demonstrates our commitment to succeed in selling our managed investment solutions into international markets where we hope to replicate the success we have enjoyed in the UK”

Recommended

FSA will choose costlier and more confusing route

Reading about Nick Bamford’s ire over the way in which Barclays are representing the financial services they can provide to their customers, I feel entitled to point out that this is exactly what I predicted several months ago whenDavid Severn was spouting on about how great depolarisation was going to be for the industry and its consumers (we knew it was baloney then and now we know it even more).

Suffolk Life appoints new sales manager

Suffolk Life has announced the appointment of John Nielsen as sales manager, reporting to John Moret, director of sales and marketing. Nielsens main responsibility at Suffolk Life will be building new relationships with IFAs and investment managers.

AWD plc grows by 7.7 per cent in 2004

AWD Holding AG announces revenue of 22.8 per cent during 2004 to 473.4m.Operating profit was boosted by 29.5 per cent to 49.3m, net profit increased by 38.9 per cent to 34.3b and earnings per share reached a record level of approximately 0.90, up by 38.9 per cent.The UK-arm of the German group, AWD plc grew […]

State of the markets: UK equity income

Artemis Income Fund manager Nick Shenton discusses the state of the UK equity income market with journalist Alexis Xydias. With the first three months of 2015 showing strong returns for both the Artemis Income Fund and UK markets generally, Nick Shenton discusses the fund’s top contributors – including overseas holdings Novartis and Bayer – and […]

Newsletter

News and expert analysis straight to your inbox

Sign up

Comments

    Leave a comment